PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+2.69%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$734M
AUM Growth
+$734M
(-9.9%)
Cap. Flow
-$47.7M
Cap. Flow
% of AUM
-6.5%
Top 10 Holdings %
Top 10 Hldgs %
35.85%
Holding
111
New
11
Increased
44
Reduced
34
Closed
21
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$19.2M |
| 2 |
Insulet
PODD
|
$17.8M |
| 3 |
Icon
ICLR
|
$11.6M |
| 4 |
Humana
HUM
|
$11.2M |
| 5 |
Boston Scientific
BSX
|
$9.71M |
Top Sells
| 1 |
Tenet Healthcare
THC
|
$17.9M |
| 2 |
Inspire Medical Systems
INSP
|
$17.4M |
| 3 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$15.6M |
| 4 |
Cencora
COR
|
$13.5M |
| 5 |
Oscar Health
OSCR
|
$12.4M |
Sector Composition
| 1 | Healthcare | 99.93% |
| 2 | Industrials | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sutro Biopharma
STRO
$85.6M
| $5.25M | 0.7% |
1,792,740
+2,689
| +0.2% | +$7.88K |
|
52
Amicus Therapeutics
FOLD
$2.42B
| $4.98M | 0.67% |
502,463
+275,740
| +122% | +$2.74M |
|
53
Replimune Group
REPL
$460M
| $4.73M | 0.63% |
+525,000
| New | +$4.73M |
|
|
PHLT
54
Performant Healthcare, Inc. Common Stock
PHLT
$602M
| $4.71M | 0.63% |
1,623,199
-35,901
| -2% | -$104K |
|
55
LivaNova
LIVN
$3.09B
| $4.67M | 0.63% |
85,159
-59,841
| -41% | -$3.28M |
|
56
UroGen Pharma
URGN
$896M
| $4.61M | 0.62% |
274,465
+90,281
| +49% | +$1.51M |
|
57
Veracyte
VCYT
$2.41B
| $4.54M | 0.61% |
209,475
-44,617
| -18% | -$967K |
|
58
MoonLake Immunotherapeutics
MLTX
$3.78B
| $4.45M | 0.6% |
101,224
+153
| +0.2% | +$6.73K |
|
|
CDMO
59
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $4.43M | 0.59% |
621,091
+350,955
| +130% | +$2.51M |
|
60
Ultragenyx Pharmaceutical
RARE
$3.04B
| $4.11M | 0.55% |
+100,000
| New | +$4.11M |
|
61
Fortrea Holdings
FTRE
$971M
| $3.57M | 0.48% |
152,769
-275,035
| -64% | -$6.42M |
|
62
Arvinas
ARVN
$580M
| $3.33M | 0.45% |
125,161
+182
| +0.1% | +$4.85K |
|
63
Nuvalent
NUVL
$5.74B
| $3.25M | 0.44% |
42,888
-4,920
| -10% | -$373K |
|
64
TG Therapeutics
TGTX
$5.03B
| $3.21M | 0.43% |
180,320
+25,281
| +16% | +$450K |
|
65
Ventyx Biosciences
VTYX
$184M
| $2.68M | 0.36% |
1,160,022
-48,077
| -4% | -$111K |
|
66
Merus
MRUS
$5.04B
| $2.67M | 0.36% |
45,152
-34,971
| -44% | -$2.07M |
|
67
Terns Pharmaceuticals
TERN
$651M
| $2.66M | 0.36% |
+390,270
| New | +$2.66M |
|
68
NewAmsterdam Pharma
NAMS
$2.8B
| $2.6M | 0.35% |
135,376
-64,935
| -32% | -$1.25M |
|
69
Esperion Therapeutics
ESPR
$490M
| $2.54M | 0.34% |
1,144,646
+1,749
| +0.2% | +$3.88K |
|
70
BioCryst Pharmaceuticals
BCRX
$1.74B
| $2.47M | 0.33% |
+400,448
| New | +$2.47M |
|
71
Dynavax Technologies
DVAX
$1.19B
| $2.43M | 0.33% |
216,822
-49,688
| -19% | -$558K |
|
72
Quanterix
QTRX
$202M
| $2.33M | 0.31% |
176,377
+265
| +0.2% | +$3.5K |
|
73
SI-BONE Inc
SIBN
$700M
| $1.98M | 0.27% |
153,015
+234
| +0.2% | +$3.03K |
|
74
Elanco Animal Health
ELAN
$8.62B
| $1.82M | 0.24% |
126,042
-75,139
| -37% | -$1.08M |
|
|
THRD
75
DELISTED
Third Harmonic Bio
THRD
| $1.73M | 0.23% |
133,325
+93,325
| +233% | +$1.21M |
|